CASI Pharmaceuticals Inc (CASI)
2.65
-0.04
(-1.49%)
USD |
NASDAQ |
Dec 20, 16:00
2.65
0.00 (0.00%)
After-Hours: 20:00
CASI Pharmaceuticals Profit Margin (Quarterly): -107.7% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| China Pharma Holding Inc | -101.6% |
| Zai Lab Ltd | -40.75% |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -137.0% |
| Return on Assets | -47.99% |
| Return on Invested Capital | -82.29% |
| Gross Profit Margin (Quarterly) | 51.91% |
| Operating Margin (Quarterly) | -103.7% |
| Return on Net Operating Assets | -87.72% |